Evolva Holding SA, Reinach, Switzerland, has entered an agreement to acquire certain assets owned by Fluxome Sciences A/S, a private Danish company that is in reconstruction. The agreement is subject to creditor and court approval, which is anticipated to occur in the next two weeks. The transaction is not expected to change Evolva’s 2012 financial projections.
Evolva’s mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. The company uses biosynthetic and evolutionary technologies to create and optimize small molecule compounds and their production routes.